Corporate social responsibility

At LEO Pharma we strive to improve the quality of life of people through innovative products and services. To truly understand the needs of patients we engage in partnerships and dialogue with patient organisations. As a member of the Association of British Pharmaceutical Industry (ABPI), LEO Pharma UK is committed to partnering in a manner that is compliant with the 2012 ABPI Code of Practice.

LEO Pharma UK has and is supporting the following UK patient organisations in 2012:

 

All Party Parliamentary Group on Skin (APPGS)

Core funding 2011 - 2012 Membership of APPGS

Monetary value: £950 

 

All Party Parliamentary Thrombosis Group (APPTG)

Core funding Corporate Membership of APPTG

Monetary value: £21,200

 

Lifeblood

Core funding – Unrestricted grant to support charity in raising awareness of VTE

Monetary value: £10,000

 

National Eczema Society (NES)

Core funding – Corporate Membership of NES

Monetary value: £6,000

 

Patient Information Forum (PIF)

Core funding – Corporate Partner

Monetary value: £10,000

 

Psoriasis Association

Financial support to provide the resource of a PR agency to cover 2012 AGM support; regional outreach and consultancy.  The Psoriasis Association to retain full editorial control.

Monetary value: £10,000

Unrestricted educational grant towards venue costs for 2012 Psoriasis Association Annual Conference and AGM

Monetary value: £10,000

 

Skcin and Skin Cancer UK

Core funding - Unrestricted grant to support charity in raising awareness of sun safety and skin cancer

Monetary Value:  £35,000

 

 

 

This information is accurate as of 1st April 2012 and reviewed quarterly.